Skip to main content
OpenTrials
Completed

NCT Number: NCT00819481

Post-Market Study of the 3DKnee™ System

The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Longo Orthopedics, Scottsdale, Arizona, United States

Loading trial locations.

About this study

Total knee replacement surgery is widely accepted as effective treatment for degenerative joint disease (DJD), osteoarthritis and rheumatoid arthritis. Relief of patient pain and return of mobility are the primary goals that can be accomplished by this surgery. The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery. The study will take place at multiple sites across the United States and be managed by the Encore Medical Clinical Affairs Department. The study will include only patients who meet the indications for use criteria for the 3DKnee™ System and who are candidates for primary knee arthroplasty.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • This must be a primary knee replacement on this knee.
  • Patient is over 18 years of age or older
  • Have knee joint disease related to one or more of the following
  • degenerative joint disease, including osteoarthritis or traumatic arthritis
  • Avascular necrosis of the femoral condyles
  • Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy
  • Moderate valgus, varus, or flexion deformities
  • Rheumatoid arthritis
  • Patient is likely to be available for evaluation for the duration of the study
  • Able and willing to sign the informed consent and follow study procedures
  • Patient is not pregnant

Exclusion criteria

  • Is younger than 18 years of age
  • If there has been a total knee replacement on this knee in the past (no revisions allowed in study)
  • Infection, or history of infection, acute or chronic, local or systemic
  • Alcoholism or other addictions
  • Muscular, neurological or vascular deficiencies which compromise the affected extremity
  • Obesity
  • Insufficient bone quality
  • Loss of ligamentous structures
  • High levels of physical activity
  • Materials sensitivity
  • Prisoner
  • Mental conditions that may interfere with the patient's ability to give an informed consent or willingness to fulfill the study requirements
  • Patient is pregnant

Treatment and study plan

3DKnee™ System

Device

Total knee replacement joint for subjects with knee osteoarthritis and willing to participate in the study.

Primary outcomes

  1. efficacy of total knee system

    Time frame: 2 year

Secondary outcomes

  1. change in Knee Society Score

    Time frame: 5 year

  2. change in pain from pre-op to post-op

    Time frame: 5 year

  3. patient satisfaction

    Time frame: 5 year

  4. change in WOMAC Osteoarthritis Index from pre-surgery

    Time frame: 5 year

  5. change in Oxford Knee Score from pre-surgery

    Time frame: 5 year

Sponsors and collaborators

Lead sponsor

Encore Medical, L.P.

Industry

Registry information

Official study title

Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700

Important dates

Study start
2009
Primary completion
2014
Study completion
2018
First posted
Jan 9, 2009
Registry last updated
Mar 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.